Design of the North Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study (NC ProCESS)

被引:22
作者
Chen, Ronald C. [1 ,2 ,3 ]
Carpenter, William R. [2 ,4 ]
Kim, Mimi [1 ]
Hendrix, Laura H. [2 ,3 ]
Agans, Robert P. [5 ]
Meyer, Anne-Marie [2 ,6 ]
Hoffmeyer, Anna [5 ]
Reeve, Bryce B. [2 ,4 ]
Nielsen, Matthew E. [1 ,2 ,7 ]
Usinger, Deborah S. [1 ,2 ]
Strigo, Tara S. [2 ]
Jackman, Anne M. [1 ]
Anderson, Mary
Godley, Paul A. [1 ,2 ,8 ]
机构
[1] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA
[5] Univ N Carolina, Carolina Survey Res Lab, Chapel Hill, NC USA
[6] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA
[7] Univ N Carolina, Sch Med, Dept Urol, Chapel Hill, NC USA
[8] Univ N Carolina, Sch Med, Dept Med, Div Hematol Oncol, Chapel Hill, NC USA
关键词
brachytherapy; comparative effectiveness research; prostate cancer; prostatectomy; radiation; QUALITY-OF-LIFE; RADICAL PROSTATECTOMY; RADIATION-THERAPY; OUTCOMES; STATISTICS; MORBIDITY; TRIAL; TIME; MEN;
D O I
10.2217/cer.14.67
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) was designed in collaboration with stakeholders to compare the effectiveness of different treatment options for localized prostate cancer. Using the Rapid Case Ascertainment system of the North Carolina Central Cancer Registry, 1,419 patients (57% of eligible) with newly-diagnosed localized prostate cancer were enrolled from January 2011 to June 2013, on average 5 weeks after diagnosis. All participants were enrolled prior to treatment and this population-based cohort is sociodemographically diverse. Prospective follow-up continues to collect data on treatments received, disease control, survival and patient-reported outcomes. This study highlights several important considerations regarding stakeholder involvement, study design and generalizability regarding comparative effectiveness research in prostate cancer.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 19 条
[1]  
[Anonymous], 2009, IN NAT PRIOR COMP EF, DOI DOI 10.17226/12648
[2]   Individualizing Quality-of-Life Outcomes Reporting: How Localized Prostate Cancer Treatments Affect Patients With Different Levels of Baseline Urinary, Bowel, and Sexual Function [J].
Chen, Ronald C. ;
Clark, Jack A. ;
Talcott, James A. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (24) :3916-3922
[3]   Symptom indexes to assess outcomes of treatment for early prostate cancer [J].
Clark, JA ;
Talcott, JA .
MEDICAL CARE, 2001, 39 (10) :1118-1130
[4]   Is It Time for Medicine-Based Evidence? [J].
Concato, John .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (15) :1641-1643
[5]  
Greenberg CC, 2013, J COMP EFFECT RES, V2, P117, DOI [10.2217/cer.12.80, 10.2217/CER.12.80]
[6]   Comparative Effectiveness of Minimally Invasive vs Open Radical Prostatectomy [J].
Hu, Jim C. ;
Gu, Xiangmei ;
Lipsitz, Stuart R. ;
Barry, Michael J. ;
D'Amico, Anthony V. ;
Weinberg, Aaron C. ;
Keating, Nancy L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (14) :1557-1564
[7]   Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial [J].
Lane, J. Athene ;
Donovan, Jenny L. ;
Davis, Michael ;
Walsh, Eleanor ;
Dedman, Daniel ;
Down, Liz ;
Turner, Emma L. ;
Mason, Malcolm D. ;
Metcalfe, Chris ;
Peters, Tim J. ;
Neal, David E. ;
Hamdy, Freddie C. .
LANCET ONCOLOGY, 2014, 15 (10) :1109-1118
[8]   Cost Implications of the Rapid Adoption of Newer Technologies for Treating Prostate Cancer [J].
Nguyen, Paul L. ;
Gu, Xiangmei ;
Lipsitz, Stuart R. ;
Choueiri, Toni K. ;
Choi, Wesley W. ;
Lei, Yin ;
Hoffman, Karen E. ;
Hu, Jim C. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (12) :1517-1524
[9]   Comparing Dosimetric, Morbidity, Quality of Life, and Cancer Control Outcomes After 3D Conformal, Intensity-Modulated, and Proton Radiation Therapy for Prostate Cancer [J].
Pearlstein, Kevin A. ;
Chen, Ronald C. .
SEMINARS IN RADIATION ONCOLOGY, 2013, 23 (03) :182-190
[10]   Prostate cancer practice patterns and quality of life: The prostate cancer outcomes study [J].
Potosky, AL ;
Harlan, LC ;
Stanford, JL ;
Gilliland, FD ;
Hamilton, AS ;
Albertsen, PC ;
Eley, JW ;
Liff, JM ;
Deapen, D ;
Stephenson, RA ;
Legler, J ;
Ferrans, CE ;
Talcott, JA ;
Litwin, MS .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (20) :1719-1724